IceCure director Sharon Levita files Form 3

IceCure Medical Ltd. director Sharon Levita filed an initial insider ownership report on Form 3.

Accepted by SEC EDGAR 03/25/2026 - 05:13 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

IceCure Medical Ltd. director Sharon Levita filed an initial insider ownership report on Form 3. The provided data shows no reportable transactions or derivative positions included in this filing.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the IceCure Medical (ICCM) Form 3 filing by Sharon Levita show?

The Form 3 filing shows that Sharon Levita is a director of IceCure Medical Ltd.. The provided data includes no reported insider transactions or derivative positions, indicating this is mainly an initial status disclosure.

Did Sharon Levita buy or sell any ICCM shares in this Form 3 filing?

No insider trades appear in this Form 3. The transaction summary shows zero buys, zero sells, and zero exercises, indicating no reportable purchases, sales, or option exercises in the data provided.

What insider role is disclosed for Sharon Levita at IceCure Medical (ICCM)?

The filing identifies Sharon Levita as a director of IceCure Medical Ltd. She is not listed as an officer and is not flagged as a ten percent owner in the structured data for this Form 3.

Does the ICCM Form 3 filing include any derivative securities for Sharon Levita?

No derivative holdings are shown in the provided data. The derivativeSummary is empty and derivative transaction counts are zero, indicating no options, warrants, or other derivatives are reported in this Form 3 excerpt.

What does a neutral net buy/sell direction mean in the ICCM Form 3 data?

The net buy/sell direction is listed as neutral with netBuySellShares at zero. This reflects the absence of reported insider purchases, sales, gifts, tax withholdings, or restructuring transactions in the summarized Form 3 data.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

LEVITA SHARON

(Last) (First) (Middle)

7 HA'ESHEL ST., PO BOX 3163

(Street)

CAESAREA 3079504

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
IceCure Medical Ltd. [ ICCM ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Sharon Levita	03/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)